|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 331.60 CHF | +0.42% |
|
-1.16% | +1.04% |
| 07-15 | Berenberg Downgrades Qiagen Rating, Price Target Amid Rising Competition, Growth Concerns | MT |
| 07-15 | Roche's Gazyva/Gazyvaro Lands Priority Review From US FDA in Nephropathy | MT |
| Market Cap | 263B 326B 285B 242B 457B 31,379B 465B 3,139B 1,233B 15,324B 1,223B 1,196B 52,904B | P/E 2026 * |
17.6x | P/E 2027 * | 16.4x |
|---|---|---|---|---|---|
| Enterprise Value | 274B 339B 296B 251B 476B 32,638B 484B 3,265B 1,283B 15,938B 1,272B 1,244B 55,025B | EV / Sales 2026 * |
4.37x | EV / Sales 2027 * | 4.09x |
| Free-Float |
88.78% | Yield 2026 * |
3.03% | Yield 2027 * | 3.1% |
Last Transcript: Roche Holding AG
| 1 day | -0.03% | ||
| 1 week | -1.16% | ||
| Current month | -0.36% | ||
| 1 month | +2.35% | ||
| 3 months | +5.77% | ||
| 6 months | -4.96% | ||
| Current year | +1.04% |
| 1 week | 324 |  | 340.3 |
| 1 month | 315.3 | | 343.2 |
| Current year | 291 | | 374.9 |
| 1 year | 243.9 | | 374.9 |
| 3 years | 212.9 | | 374.9 |
| 5 years | 212.9 | | 404.2 |
| 10 years | 206.35 | | 404.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 15/03/2023 | |
Alan Hippe
DFI | Director of Finance/CFO | 59 | 06/06/2011 |
| Chief Operating Officer | - | 01/10/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
André Hoffmann
BRD | Director/Board Member | 68 | 01/01/1996 |
Severin Schwan
CHM | Chairman | 59 | 15/03/2023 |
| Director/Board Member | 73 | 03/03/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 27/3/26 | Sell | 3,851 | 0.0036% | |||
| 26/2/26 | Buy | 7,984 | 0.0011% | |||
| 2/2/26 | Sell | 111 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.42% | -1.16% | +29.43% | +23.64% | 326B | |
| +1.37% | -3.77% | +48.28% | +161.91% | 1,031B | |
| +1.02% | -4.13% | +50.75% | +56.16% | 595B | |
| +3.06% | +0.66% | +31.99% | +86.57% | 431B | |
| +1.03% | -0.84% | +29.58% | +45.15% | 277B | |
| +0.49% | -5.44% | +21.00% | +23.80% | 263B | |
| +1.59% | +4.89% | -22.56% | -37.35% | 224B | |
| +2.89% | +1.27% | +23.15% | +61.62% | 193B | |
| +2.28% | -0.22% | +22.48% | +73.64% | 164B | |
| +0.83% | +3.20% | +1.69% | -30.21% | 141B | |
| Average | +1.41% | -3.09% | +23.58% | +46.49% | 364.58B | |
| Weighted average by Cap. | +1.35% | -4.02% | +33.03% | +75.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 62.6B 77.44B 67.69B 57.44B 109B 7,462B 111B 747B 293B 3,644B 291B 284B 12,580B | 65.29B 80.76B 70.59B 59.91B 113B 7,782B 115B 779B 306B 3,800B 303B 297B 13,120B |
| Net income | 15.22B 18.83B 16.46B 13.97B 26.44B 1,815B 26.9B 182B 71.33B 886B 70.73B 69.18B 3,060B | 16.35B 20.22B 17.68B 15B 28.39B 1,949B 28.88B 195B 76.59B 952B 75.94B 74.28B 3,285B |
| Net Debt | 10.56B 13.06B 11.41B 9.69B 18.33B 1,258B 18.65B 126B 49.45B 614B 49.04B 47.96B 2,121B | 3.92B 4.84B 4.23B 3.59B 6.8B 467B 6.92B 46.69B 18.34B 228B 18.19B 17.79B 787B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/07/26 | CHF 331.60 | +0.42% | 594,766 |
| 15/07/26 | CHF 330.20 | +0.98% | 676,304 |
| 14/07/26 | CHF 327.00 | -1.12% | 639,915 |
| 13/07/26 | CHF 330.70 | -1.75% | 838,250 |
| 10/07/26 | CHF 336.60 | +0.33% | 996,548 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROP Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition